Cargando…

Premorbid obesity, but not nutrition, prevents critical illness‐induced muscle wasting and weakness

BACKGROUND: The ‘obesity paradox’ of critical illness refers to better survival with a higher body mass index. We hypothesized that fat mobilized from excess adipose tissue during critical illness provides energy more efficiently than exogenous macronutrients and could prevent lean tissue wasting. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goossens, Chloë, Marques, Mirna Bastos, Derde, Sarah, Vander Perre, Sarah, Dufour, Thomas, Thiessen, Steven E., Güiza, Fabian, Janssens, Thomas, Hermans, Greet, Vanhorebeek, Ilse, De Bock, Katrien, Van den Berghe, Greet, Langouche, Lies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326828/ https://www.ncbi.nlm.nih.gov/pubmed/27897405 http://dx.doi.org/10.1002/jcsm.12131

Ejemplares similares

Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
por: Marques, Mirna Bastos, et al.
Publicado: (2013)

OR20-6 Ketones and Sepsis-Induced Muscle Weakness: Signal or Fuel for Protection?
por: Weckx, Ruben, et al.
Publicado: (2019)

Adipose tissue protects against sepsis-induced muscle weakness in mice: from lipolysis to ketones
por: Goossens, Chloë, et al.
Publicado: (2019)

Efficacy and safety of ketone ester infusion to prevent muscle weakness in a mouse model of sepsis-induced critical illness
por: Weckx, Ruben, et al.
Publicado: (2022)

On the Role of Illness Duration and Nutrient Restriction in Cholestatic Alterations that Occur During Critical Illness
por: Jenniskens, Marc, et al.
Publicado: (2018)

SUN-548 Ketone Bodies in Critical Illness Alter Cholesterol Synthesis in Skeletal Muscle, Interlinked with Protection Against Weakness
por: Goossens, Chloë, et al.
Publicado: (2020)

Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
por: Vankrunkelsven, Wouter, et al.
Publicado: (2023)

Obesity attenuates inflammation, protein catabolism, dyslipidaemia, and muscle weakness during sepsis, independent of leptin
por: Vankrunkelsven, Wouter, et al.
Publicado: (2022)

Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
por: Goossens, Chloë, et al.
Publicado: (2021)

OR16-4 The Growth Hormone Axis in Relation to Muscle Weakness in the ICU: Effect of Early Macronutrient Deficit
por: Van Dyck, Lisa, et al.
Publicado: (2019)

Proliferation and differentiation of adipose tissue in prolonged lean and obese critically ill patients
por: Goossens, Chloë, et al.
Publicado: (2017)

The role of pro-opiomelanocortin in the ACTH–cortisol dissociation of sepsis
por: Téblick, Arno, et al.
Publicado: (2021)

Identification of the toxic threshold of 3-hydroxybutyrate-sodium supplementation in septic mice
por: Weckx, Ruben, et al.
Publicado: (2021)

Critical illness induces alternative activation of M2 macrophages in adipose tissue
por: Langouche, Lies, et al.
Publicado: (2011)

The Role of Autophagy in Critical Illness-induced Liver Damage
por: Thiessen, Steven E., et al.
Publicado: (2017)

OR19-06 Sepsis-Induced Critical Illness in Mice Alters Key Regulators of ACTH Production and Secretion Within the Anterior Pituitary Gland
por: Téblick, Arno, et al.
Publicado: (2020)

Impact of Hydrocortisone and of CRH Infusion on the Hypothalamus-Pituitary-Adrenocortical Axis of Septic Male Mice
por: Téblick, Arno, et al.
Publicado: (2021)

Skeletal Muscle Myokine Expression in Critical Illness, Association With Outcome and Impact of Therapeutic Interventions
por: Vanhorebeek, Ilse, et al.
Publicado: (2023)

ICU-acquired weakness
por: Vanhorebeek, Ilse, et al.
Publicado: (2020)

Impact of withholding early parenteral nutrition in adult critically ill patients on ketogenesis in relation to outcome
por: De Bruyn, Astrid, et al.
Publicado: (2021)

OR26-4 Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
por: Téblick, Arno, et al.
Publicado: (2022)

DNA methylation alterations in muscle of critically ill patients
por: Van Dyck, Lisa, et al.
Publicado: (2022)

Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin
por: Langouche, Lies, et al.
Publicado: (2009)

Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients
por: Gunst, Jan, et al.
Publicado: (2021)

Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
por: Marques, M, et al.
Publicado: (2013)

SAT-155 Temporal Activation of the Unfolded Protein Response and Concomitant Downregulation of Key Hepatic Transcription Factors in Critical Illness
por: Vankrunkelsven, Wouter, et al.
Publicado: (2019)

ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study
por: Peeters, Bram, et al.
Publicado: (2018)

Impact of duration of critical illness and level of systemic glucocorticoid availability on tissue-specific glucocorticoid receptor expression and actions: A prospective, observational, cross-sectional human and two translational mouse studies
por: Téblick, Arno, et al.
Publicado: (2022)

Clinical review: intensive care unit acquired weakness
por: Hermans, Greet, et al.
Publicado: (2015)

Effect of withholding early parenteral nutrition in PICU on ketogenesis as potential mediator of its outcome benefit
por: De Bruyn, Astrid, et al.
Publicado: (2020)

OR17-1 Changes in the Hypothalamic-Pituitary-Adrenal Axis during Pediatric Critical Illness
por: Jacobs, An, et al.
Publicado: (2019)

Nonthyroidal Illness Syndrome Across the Ages
por: Langouche, Lies, et al.
Publicado: (2019)

Prevalence and Prognostic Value of Abnormal Liver Test Results in Critically Ill Children and the Impact of Delaying Parenteral Nutrition*
por: Jenniskens, Marc, et al.
Publicado: (2018)

Persisting neuroendocrine abnormalities and their association with physical impairment 5 years after critical illness
por: Vanhorebeek, Ilse, et al.
Publicado: (2021)

The epigenetic legacy of ICU feeding and its consequences
por: Vanhorebeek, Ilse, et al.
Publicado: (2023)

Anterior pituitary function in critical illness
por: Téblick, Arno, et al.
Publicado: (2019)

Hyperglycemia and insulin resistance in COVID-19 versus non-COVID critical illness: Are they really different?
por: Langouche, Lies, et al.
Publicado: (2021)

Adrenocortical function during prolonged critical illness and beyond: a prospective observational study
por: Peeters, Bram, et al.
Publicado: (2018)

The association of hypoglycemia with outcome of critically ill children in relation to nutritional and blood glucose control strategies
por: Gunst, Jan, et al.
Publicado: (2023)

Intensive care unit acquired muscle weakness in COVID-19 patients
por: Van Aerde, Nathalie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ohbrkoe121konlr8p3u5gj9pji